It is with great sadness we announce the death of Professor Michel Dreux. Professor Dreux was a professor at the University of Orléans, France.
It is with great sadness we announce the death of Professor Michel Dreux. Professor Dreux was a professor at the University of Orléans, France. Head of a Chromatography Laboratory, he merged his team with a team of organic chemists to create the Bioorganic and Analytical Chemistry Laboratory (LCBA), which became the Institute of Organic and Analytical Chemistry (ICOA) in 1995, by merging with other carbohydrateâsynthesisâfocused laboratories.
Head of the Analytical Department in this Institute, he continued his research on both liquid chromatography and capillary electrophoresis. He taught hundreds of students at the University of Orléans, and supported several Ph.D. studies in his laboratories. He was highly and unanimously appreciated by both his colleagues and students for his readiness to help, the relevance of his advice, and his kindness.
Focused on carbohydrate and non-chromophoric chemical and biochemical species (amino acids, ions) analysis in the 1980s, Professor Dreux developed on his own a first prototype of an evaporative light-scattering detector (ELSD). This first device was the pioneer of several generations of low-temperature evaporative lightâscattering detectors (LT-ELSD).
He produced numerous scientific publications and several patents to improve the LT-ELSD technology and to emphasize the relevance of this detection mode in liquid chromatography and supercritical fluid chromatography. His works on the detector originated several Ph.D. and scientists research programmes within the University. He also received the “Palmes Académiques” award, which is a specific decoration for services to Education in France.
In 2002, he entirely joined Sedere as the Scientific Director in order to continue the development of new ELSDs. He was a friend and a mentor for most people at his University and at Sedere, and is terribly missed today. - Rodolphe Pennanec, Sedere
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.